Ainos (NASDAQ:AIMD – Get Free Report) and Quantum (NASDAQ:QMCO – Get Free Report) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, risk and profitability.
Analyst Recommendations
This is a breakdown of recent ratings for Ainos and Quantum, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ainos | 1 | 0 | 0 | 0 | 1.00 |
| Quantum | 1 | 0 | 5 | 0 | 2.67 |
Quantum has a consensus target price of $28.33, indicating a potential upside of 84.70%. Given Quantum’s stronger consensus rating and higher possible upside, analysts clearly believe Quantum is more favorable than Ainos.
Insider & Institutional Ownership
63.7% of Quantum shares are owned by institutional investors. 9.8% of Ainos shares are owned by insiders. Comparatively, 41.0% of Quantum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares Ainos and Quantum’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ainos | N/A | -217.50% | -67.87% |
| Quantum | -73.54% | -3.99% | 2.70% |
Risk and Volatility
Ainos has a beta of 2.65, indicating that its stock price is 165% more volatile than the S&P 500. Comparatively, Quantum has a beta of 3.23, indicating that its stock price is 223% more volatile than the S&P 500.
Valuation & Earnings
This table compares Ainos and Quantum”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ainos | $120,000.00 | 89.38 | -$14.77 million | ($2.52) | -0.49 |
| Quantum | $279.58 million | 2.17 | -$101.05 million | ($10.89) | -1.41 |
Ainos has higher earnings, but lower revenue than Quantum. Quantum is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.
Summary
Quantum beats Ainos on 9 of the 14 factors compared between the two stocks.
About Ainos
Ainos, Inc. is a healthcare technology company focused on developing artificial intelligence-enabled point-of-care testing, telehealth solutions and low-dose interferon therapeutics. Its technologies are intended to support faster, more accessible testing and treatment in clinical and other healthcare settings. The company’s development portfolio has included AI Nose, a platform designed to analyze volatile organic compounds for potential disease screening, as well as Ainos Flora, a point-of-care molecular testing product being developed for the detection of common vaginal infections.
About Quantum
Quantum Corporation provides data storage and management solutions for organizations that create and retain large volumes of unstructured data, including video, images and other digital content. Its customers include businesses and institutions in areas such as media and entertainment, government, life sciences and industrial markets. The company’s offerings include StorNext shared-storage and data-management software, Scalar tape libraries for backup and archiving, and ActiveScale object storage.
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
